Anti-MGAT1 antibody [EPR14247]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(5 Reviews)
|
(11 Publications)
Rabbit Recombinant Monoclonal MGAT1 antibody. Suitable for WB and reacts with Human samples. Cited in 11 publications.
View Alternative Names
GGNT1, GLCT1, GLYT1, MGAT, MGAT1, N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I, GNT-I, GlcNAc-T I
- WB
Supplier Data
Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)
All lanes:
Western blot - Anti-MGAT1 antibody [EPR14247] (ab180578) at 1/10000 dilution
All lanes:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 51 kDa
false
- WB
Supplier Data
Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)
All lanes:
Western blot - Anti-MGAT1 antibody [EPR14247] (ab180578) at 1/2000 dilution
All lanes:
293 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit igG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 51 kDa
false
- WB
CiteAb
Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)
MGAT1 western blot using anti-MGAT1 antibody [EPR14247] ab180578. Publication image and figure legend from Fisher, P., Spencer, H., et al., 2019, Cell Rep, PubMed 31018136.
ab180578 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab180578 please see the product overview.
Predicting Organizational Changes in Trafficking Defective Cell Lines(A and B) Observed and simulated glycan profiles of Cog4KD HeLa cell lines (A) and Cog4KO HEK293T cell lines (B). Error bars for glycan profiling are SEM for n = 3.(C) Total effective enzymatic rate changes predicted by the model following fitting as a result of Cog4 perturbation. The x axis is on a log scale. Error bars for total effective enzymatic rates and distributions are SD for n = 20 (Cog4KD HeLa) and n = 21 (Cog4KO HEK293T) individual fitting procedures.(D) Western blot analysis of endogenous MGAT1, GalT, and FUT8 and quantification normalized to WT HEK293T. Error bars for western blot quantification are SD for n = 3. ns, not significant; *p < 0.05 for a Student's t test.(E) Predicted relative distribution of MAN1 following the fitting of WT and Cog4KD HeLa glycan profiles.(F) Predicted relative distributions of selected enzymes in WT and Cog4KO HEK293T cells in each cisterna normalized to the total predicted effective enzymatic rate for each enzyme for each cell line.(G) Airyscan confocal microscopy of GM130 and exogenous GalT-YFP in nocodazole-treated WT and Cog4KO HEK293T cell lines.(H) Pearson's correlation coefficient for WT and Cog4KO HEK293T cells. Pearson's correlation coefficients were calculated for each Golgi stack, and error bars are SD for n = 4 cells with 151 (WT) and 131 (Cog4KO) stacks. ***p < 0.001 for a Student's t test.See also Figures S3 and S6 and Table S3.
false
Related conjugates and formulations (1)
-
Anti-MGAT1 antibody [EPR14247] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MGAT1 plays an essential role in protein folding stability and function by modifying N-glycans attached to nascent proteins. The enzyme acts as part of a complex that includes other enzymes like MGAT2 MGAT3 and MGAT5 in the glycan biosynthesis pathway. MGAT1's activity significantly influences cell-cell communication signaling and immune responses. Its function enhances the diversity and biological roles of glycoproteins within cells impacting various physiological processes.
Pathways
MGAT1 is a significant player in the protein glycosylation and folding pathways. It interacts with proteins like MGAT2 and galectin-3 indicating its involvement in broader metabolic processes. N-glycan biosynthesis pathway is its primary pathway where it contributes by enabling the elongation and branching of N-glycan structures. This glycosylation process affects cellular processes such as signal transduction and protein trafficking through downstream effects on glycoproteins.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Traffic (Copenhagen, Denmark) 24:52-75 PubMed36468177
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 41:111679 PubMed36417860
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 32:1594-1610 PubMed34161137
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 17:e1009244 PubMed33539469
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 8:212 PubMed32300591
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cells 8: PubMed31847122
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 7:118 PubMed31334232
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 27:1231-1243.e6 PubMed31018136
2019
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33:2823-2835 PubMed30307765
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 130:3234-3247 PubMed28775154
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com